Clinical data | |
---|---|
Trade names | Oramon, Somnifane, Allonal |
Other names | aprobarbitone, allylpropymal, Alurate, 5-isopropyl- 5-allylbarbituric acid |
AHFS/Drugs.com | International Drug Names |
Drug class | Barbiturate |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.908 |
Chemical and physical data | |
Formula | C10H14N2O3 |
Molar mass | 210.233 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Aprobarbital (or aprobarbitone), sold under the brand names Oramon, Somnifaine, and Allonal, is a barbiturate derivative invented in the 1920s by Ernst Preiswerk. It has sedative, hypnotic, and anticonvulsant properties, and was used primarily for the treatment of insomnia.[2] Aprobarbital was never as widely used as more common barbiturate derivatives such as phenobarbital and is now rarely prescribed. It has been largely replaced by newer drugs with a better safety margin.